RxSight, Inc.RR

RxSight, Inc.

28.36USDR
+0.15+0.53%
At close at Mar 1, 00:49 GMT
USD
No trades
See on Supercharts
Back

EBITDA of RxSight, Inc.

Annual data
2020
2021
2022
2023
2024
TTM
‪‪−60.00 M‬‬
‪‪−45.00 M‬‬
‪‪−30.00 M‬‬
‪‪−15.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
TTM
‪‪−33.23 M‬‬
+‪‪1.00 K‬‬
‪0.00‬%
2024
‪‪−33.23 M‬‬
+‪‪12.61 M‬‬
+‪27.50‬%
2023
‪‪−45.84 M‬‬
+‪‪13.45 M‬‬
+‪22.69‬%
2022
‪‪−59.30 M‬‬
‪‪−10.50 M‬‬
‪−21.51‬%
2021
‪‪−48.80 M‬‬
‪‪−17.41 M‬‬
‪−55.45‬%
2020
‪‪−31.39 M‬‬
+‪‪11.27 M‬‬
+‪26.41‬%
Quarterly data
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−14.00 M‬‬
‪‪−10.50 M‬‬
‪‪−7.00 M‬‬
‪‪−3.50 M‬‬
‪0.00‬
Period
Value
Change
Change %
Q4 '24
‪‪−8.11 M‬‬
‪‪−20.00 K‬‬
‪−0.25‬%
Q3 '24
‪‪−8.09 M‬‬
‪‪−572.00 K‬‬
‪−7.61‬%
Q2 '24
‪‪−7.51 M‬‬
+‪‪2.02 M‬‬
+‪21.16‬%
Q1 '24
‪‪−9.53 M‬‬
+‪‪238.00 K‬‬
+‪2.44‬%
Q4 '23
‪‪−9.77 M‬‬
+‪‪1.61 M‬‬
+‪14.18‬%
Q3 '23
‪‪−11.38 M‬‬
+‪‪1.21 M‬‬
+‪9.63‬%
Q2 '23
‪‪−12.60 M‬‬
‪‪−497.00 K‬‬
‪−4.11‬%
Q1 '23
‪‪−12.10 M‬‬
+‪‪1.93 M‬‬
+‪13.76‬%
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21